https://www.selleckchem.com/pr....oducts/2-hydroxybenz
7% versus 2.0%, hazard ratio, 1.81, P=0.034; CTA 5.0% versus 2.2%, hazard ratio, 1.85; P=0.044) and positive tests (stress 8.3% versus 2.0%, hazard ratio, 3.50; CTA 9.2% versus 2.2%, hazard ratio, 3.66; P less then 0.001). Twenty-four-month costs were higher for inconclusive tests than negative tests by $2905 (stress) and $4030 (CTA). CONCLUSIONS Among patients with stable chest pain undergoing a noninvasive test, inconclusive results occurred in 6% of CTA and 10% of stress tests. Compared with those with conclusive negativ